2 | Golob Lab https://goloblab.org/publication_types/2/ 2 Source Themes Academic (https://sourcethemes.com/academic/)en-us© Jonathan Golob 2024Mon, 01 Jan 2024 00:00:00 +0000 https://goloblab.org/img/icon-192.png 2 https://goloblab.org/publication_types/2/ Discovery of sparse, reliable omic biomarkers with Stabl https://goloblab.org/publication/hedou-discovery-2024/ Mon, 01 Jan 2024 00:00:00 +0000 https://goloblab.org/publication/hedou-discovery-2024/ Microbiome preterm birth DREAM challenge: Crowdsourcing machine learning approaches to advance preterm birth research https://goloblab.org/publication/golob-microbiome-2023-1/ Fri, 01 Dec 2023 00:00:00 +0000 https://goloblab.org/publication/golob-microbiome-2023-1/ Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation https://goloblab.org/publication/riwes-feasibility-2023/ Wed, 01 Nov 2023 00:00:00 +0000 https://goloblab.org/publication/riwes-feasibility-2023/ MaLiAmPi enables generalizable and taxonomy-independent microbiome features from technically diverse 16S-based microbiome studies https://goloblab.org/publication/minot-maliampi-2023/ Wed, 01 Nov 2023 00:00:00 +0000 https://goloblab.org/publication/minot-maliampi-2023/ The Microbiome in Quiescent Crohn’s Disease with Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways https://goloblab.org/publication/golob-microbiome-2023/ Wed, 01 Nov 2023 00:00:00 +0000 https://goloblab.org/publication/golob-microbiome-2023/ Human Microbiomes and Disease for the Biomedical Data Scientist https://goloblab.org/publication/golob-human-2023/ Mon, 01 May 2023 00:00:00 +0000 https://goloblab.org/publication/golob-human-2023/ The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers https://goloblab.org/publication/golob-fecal-2023/ Mon, 01 May 2023 00:00:00 +0000 https://goloblab.org/publication/golob-fecal-2023/ 504. Latent HHV7 Infection Attenuates Beneficial Host-Microbe Interactions in the Human Gut https://goloblab.org/publication/lauder-504-2022/ Thu, 01 Dec 2022 00:00:00 +0000 https://goloblab.org/publication/lauder-504-2022/ A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe ARDS From COVID-19 https://goloblab.org/publication/bowdish-randomized-2022/ Thu, 01 Sep 2022 00:00:00 +0000 https://goloblab.org/publication/bowdish-randomized-2022/ Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction https://goloblab.org/publication/sugihara-mucolytic-2022/ Fri, 01 Jul 2022 00:00:00 +0000 https://goloblab.org/publication/sugihara-mucolytic-2022/ Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation https://goloblab.org/publication/pianko-host-microbe-2022/ Wed, 01 Jun 2022 00:00:00 +0000 https://goloblab.org/publication/pianko-host-microbe-2022/ A potential pathogenic association between periodontal disease and Crohn's disease https://goloblab.org/publication/imai-potential-2021/ Wed, 01 Dec 2021 00:00:00 +0000 https://goloblab.org/publication/imai-potential-2021/ Comparative Analysis of Public RNA-Sequencing Data from Human Intestinal Enteroid (HIEs) Infected with Enteric RNA Viruses Identifies Universal and Virus-Specific Epithelial Responses https://goloblab.org/publication/cieza-comparative-2021/ Tue, 01 Jun 2021 00:00:00 +0000 https://goloblab.org/publication/cieza-comparative-2021/ geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response https://goloblab.org/publication/minot-geneshot-2021/ Sat, 01 May 2021 00:00:00 +0000 https://goloblab.org/publication/minot-geneshot-2021/ SARS-CoV-2 vaccines: a triumph of science and collaboration https://goloblab.org/publication/golob-sars-cov-2-2021/ Sat, 01 May 2021 00:00:00 +0000 https://goloblab.org/publication/golob-sars-cov-2-2021/ Signal vs. noise: how to analyze the microbiome and make progress on antimicrobial resistance https://goloblab.org/publication/golob-signal-2021/ Thu, 01 Apr 2021 00:00:00 +0000 https://goloblab.org/publication/golob-signal-2021/ Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer https://goloblab.org/publication/chang-targeting-2021/ Mon, 01 Mar 2021 00:00:00 +0000 https://goloblab.org/publication/chang-targeting-2021/ The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19 https://goloblab.org/publication/goldstein-prevalence-2021/ Mon, 01 Feb 2021 00:00:00 +0000 https://goloblab.org/publication/goldstein-prevalence-2021/ In silico benchmarking of metagenomic tools for coding sequence detection reveals the limits of sensitivity and precision https://goloblab.org/publication/golob-silico-2020/ Thu, 01 Oct 2020 00:00:00 +0000 https://goloblab.org/publication/golob-silico-2020/ COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-Control Study https://goloblab.org/publication/sharma-covid-19-2020/ Tue, 01 Sep 2020 00:00:00 +0000 https://goloblab.org/publication/sharma-covid-19-2020/ Cytomegalovirus viral load kinetics as surrogate endpoints after allogeneic transplantation https://goloblab.org/publication/duke-cytomegalovirus-2020/ Tue, 01 Sep 2020 00:00:00 +0000 https://goloblab.org/publication/duke-cytomegalovirus-2020/ Tocilizumab for treatment of mechanically ventilated patients with COVID-19 https://goloblab.org/publication/somers-tocilizumab-2020/ Wed, 01 Jul 2020 00:00:00 +0000 https://goloblab.org/publication/somers-tocilizumab-2020/ Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD https://goloblab.org/publication/golob-butyrogenic-2019/ Tue, 01 Oct 2019 00:00:00 +0000 https://goloblab.org/publication/golob-butyrogenic-2019/